Evidence map›Paper›PMID 33306749›Full record

SynthesisPloS one2020

Microfluidics and organ-on-a-chip technologies: A systematic review of the methods used to mimic bone marrow.

Gabriel Santos Rosalem, Libardo Andrés Gonzáles Torres, Estevam Barbosa de Las Casas, Fernando Augusto Siqueira Mathias, Jeronimo Conceição Ruiz, Maria Gabriela Reis Carvalho

Abstract readSystematic Review
In one paragraph

Synthesis in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. 3DACS biomaterials science & engineering · 2026
    Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. The Therapeutic Scope of Orofacial Mesenchymal Stem Cells.Bioengineering (Basel, Switzerland) · 2025
    Review
  10. Stem Cell Niche Concept: Search for Current Expert Consensus.International journal of molecular sciences · 2025
    Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Organ-on-chip for advancing CAR therapy.Clinical & translational immunology · 2025
    Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Gabriel Santos RosalemMechanical Engineering Graduate Program, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Libardo Andrés Gonzáles TorresInstitute of Science and Technology, Universidade Federal dos Vales do Jequitinhonha e Mucuri, Diamantina, Brazil.
Estevam Barbosa de Las CasasDepartment of Structural Engineering, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Fernando Augusto Siqueira MathiasBiosystems and Genomics Group, René Rachou Institute, Oswaldo Cruz Foundation, Belo Horizonte, Brazil.
Jeronimo Conceição RuizBiosystems and Genomics Group, René Rachou Institute, Oswaldo Cruz Foundation, Belo Horizonte, Brazil.
Maria Gabriela Reis CarvalhoBiosystems and Genomics Group, René Rachou Institute, Oswaldo Cruz Foundation, Belo Horizonte, Brazil.ORCID 0000-0002-0806-2033

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone marrow (BM) is an organ responsible for crucial processes in living organs, e. g., hematopoiesis. In recent years, Organ-on-a-Chip (OoC) devices have been used to satisfy the need for in vitro systems that better mimic the phenomena occurring in the BM microenvironment. Given the growing interest in these systems and the diversity of developed devices, an integrative systematic literature review is required. We have performed this review, following the PRISMA method aiming to identify the main characteristics and assess the effectiveness of the devices that were developed to represent the BM. A search was performed in the Scopus, PubMed, Web of Science and Science Direct databases using the keywords (("bone marrow" OR "hematopoietic stem cells" OR "haematopoietic stem cells") AND ("organ in a" OR "lab on a chip" OR "microfluidic" OR "microfluidic*" OR ("bioreactor" AND "microfluidic*"))). Original research articles published between 2009 and 2020 were included in the review, giving a total of 21 papers. The analysis of these papers showed that their main purpose was to study BM cells biology, mimic BM niches, model pathological BM, and run drug assays. Regarding the fabrication protocols, we have observed that polydimethylsiloxane (PDMS) material and soft lithography method were the most commonly used. To reproduce the microenvironment of BM, most devices used the type I collagen and alginate. Peristaltic and syringe pumps were mostly used for device perfusion. Regarding the advantages compared to conventional methods, there were identified three groups of OoC devices: perfused 3D BM; co-cultured 3D BM; and perfused co-cultured 3D BM. Cellular behavior and mimicking their processes and responses were the mostly commonly studied parameters. The results have demonstrated the effectiveness of OoC devices for research purposes compared to conventional cell cultures. Furthermore, the devices have a wide range of applicability and the potential to be explored.

Indexed as

Lab-On-A-Chip DevicesMicrofluidicsAnimalsBiocompatible MaterialsBiomimeticsBone MarrowHumansBiocompatible Materials

Identifiers

PMID33306749
PMCPMC7732112

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.